ISSN: 2161-0681

Revista de patología clínica y experimental

Acceso abierto

Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Indexado en
  • Índice Copérnico
  • Google Académico
  • sherpa romeo
  • Abrir puerta J
  • Revista GenámicaBuscar
  • TOC de revistas
  • Directorio de publicaciones periódicas de Ulrich
  • Búsqueda de referencia
  • Universidad Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • publones
  • Fundación de Ginebra para la educación y la investigación médicas
  • Pub Europeo
  • ICMJE
Comparte esta página

Abstracto

Use of Intraoperative Frozen Section during Mediastinoscopy

Paul A Perry, Barry Hird R, Richard K Orr and Christophe L Nguyen

Introduction: Staging of mediastinal lymph nodes (MLN) by mediastinoscopy can be of critical importance in assessing candidacy for lung resection. Mediastinoscopy is often performed as a sole procedure, with permanent pathology results guiding subsequent intervention. Our practice has been to perform mediastinoscopy followed by immediate surgical resection, as indicated, based on intraoperative frozen section (FS) assessment. The goal of our review is to evaluate the reliability of FS when compared to permanent section (PS) and to investigate any discordant findings. Materials and methods: A retrospective review of patients with lung cancer that underwent mediastinoscopy from June 2006 to January 2011. All received clinical staging according to NCCN guidelines and were considered potential candidates for surgical resection. Results for FS and PS of MLN were assessed. Results: Staging mediastinoscopy was performed on 191 patients, with a total of 549 MLN undergoing FS and PS analysis. Concordance between FS and PS was found in 545 MLN (99.3%). Discordance was found in 4 MLN (0.7%), each in a different patient. All 4 discordant MLN were initially negative on FS and then found to be positive on PS. Overall accuracy of FS analysis for detecting all malignancy was 97.9%, with 94.3% sensitivity, 100% specificity, 96.7% negative predicted value, and 100% positive predicted value. Conclusion: Our data suggest that for lung cancer patients with potentially resectable tumors, immediate FS analysis of MLN followed by definitive surgery is a reliable and safe strategy. Discordance with final pathology was rare (0.7%) and resulted in improper staging in 1 (0.5%) patient. Advantages of this “fast-track” approach include less medical costs and hastening of time from diagnosis/staging to definitive treatment.